SCHEMBL253105

SCHEMBL253105

O=C(O)OC(=O)C1=Cc2ccccc2-c2cc3ccccc3n2C1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 4/20 0.32
KDM4E B2RXH2 2/20 0.32
HPGD P15428 2/20 0.32
KMT2A Q03164 2/20 0.32
HSD17B10 Q99714 1/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
RECQL P46063 1/20 0.32
SIGMAR1 Q99720 3/20 0.32
DAO P14920 1/20 0.31
MCL1 Q07820 1/20 0.31
MTNR1A P48039 1/20 0.31
MTNR1B P49286 1/20 0.31
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL51354 0.86 DAO (0.38) HTR1AL3MBTL1ALDH1A1KDM4EHPGD
SCHEMBL3941964 0.74 RPS6KA3 (0.43)
SCHEMBL841220 0.74 ALDH1A1 (0.42) HTR1AL3MBTL1ALDH1A1SIGMAR1
SCHEMBL3938873 0.74 RPS6KA3 (0.45) L3MBTL1ALDH1A1KDM4EKMT2AHSD17B10
SCHEMBL3946964 0.70 RPS6KA2 (0.41) ALDH1A1
SCHEMBL2421457 0.68 KDM4E (0.49) HTR1AALDH1A1KDM4EHPGDKMT2A
SCHEMBL641455 0.64 KMT2A (0.37) HTR1AALDH1A1KDM4EHPGDKMT2A
SCHEMBL51096 0.62 MCL1 (0.38) L3MBTL1ALDH1A1KDM4EHPGDKMT2A
SCHEMBL854124 0.61 KMT2A (0.34) L3MBTL1ALDH1A1KDM4EKMT2AMEN1
SCHEMBL50820 0.61 RPS6KA3 (0.49) ALDH1A1KDM4EHPGDKMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401280-A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors Bristol-Myers Squibb Company (US) 2012-01-04 EP disclosed
WO-2010099159-A1 CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-09-02 WO disclosed